Abstract
The new coronavirus disease 2019 (COVID19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide at a rapid rate. There is no clinically automated tool to quantify the infection of COVID-19 patients. Automatic segmentation of lung opacification from computed tomography (CT) images provides excellent potential, which is of great significance for judging the disease development and treatment response of the patients. However, the segmentation of lung opacification from CT slices still faces some challenges, including the complexity and variability features of the opacity regions, the small difference between the infected and healthy tissues, and the noise of CT images. Besides, due to the limited medical resources, it is impractical to obtain a large amount of data in a short time, which further hinders the training of deep learning models. To answer these challenges, we proposed a novel spatial and channel-wise coarse-to-fine attention network (SCOAT-Net) inspired by the biological vision mechanism, which is for the segmentation of COVID-19 lung opacification from CT Images. SCOAT-Net has the spatial-wise attention module and the channel-wise attention module to attract the self-attention learning of the network, which serves to extract the practical features at the pixel and channel level successfully. Experiments show that our proposed SCOAT-Net achieves better results compared to state-of-the-art image segmentation networks.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by Key Area R&D Program of Guangdong province with Grant No.2018B03033801, National Key Research and Development Project (2018ZX10723203-001-002), Key Emergency Project of Pneumonia Epidemic of novel coronavirus infection (2020SK3006), Emergency Project of Prevention and Control for COVID-19 of Central South University (160260005) and Foundation from Changsha Scientific and Technical bureau, China (kq2001001).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was granted from the local ethics committees of Central South University and University of Electronic Science and Technology of China.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
# This work was supported by Key Area R&D Program of Guangdong province with Grant No.2018B03033801, National Key Research and Development Project (2018ZX10723203–001–002), Key Emergency Project of Pneumonia Epidemic of novel coronavirus infection (2020SK3006), Emergency Project of Prevention and Control for COVID-19 of Central South University (160260005) and Foundation from Changsha Scientific and Technical bureau, China (kq2001001).
Data Availability
All data in this study are not available for downloading and re-using.
